- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05846477
MySpine MC Versus MySpine Standard (MC vs STD)
Prospective Comparative Monocentric Research Project Study to Compare Cortical Bone Trajectory Screw Insertion Technique With Pedicle Screw Insertion Technique by Use of Patient Specific Drill Guides
Study Overview
Status
Intervention / Treatment
Detailed Description
Adult subjects, among those whose clinical condition makes them eligible for a spinal stabilization and meeting the inclusion/exclusion criteria, will be invited to participate to the research project and ask to sign a consent in order to further use of personal and clinical data collected during standard practice visit.
The primary objective of the research project is to compare clinical outcomes, in terms of assessing the main outcomes of importance to patients with back problems (pain, function, symptom-specific well-being, quality of life, disability), of spine surgery with cortical bone trajectory screw placement technique respect the traditional pedicle screw placement technique. Preoperative data and collected during visit as per standard routine at 6 weeks, 3, 6 and 12 months postop will be recoreded and assessed for the purpose of this research project.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland
- Recruiting
- Schulthess Klinik
-
Contact:
- François Porchet, Dr
- Phone Number: +41 79 385 72 10
- Email: francois.porchet@kws.ch
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patients affected by degenerative disc disease, osteochondrosis and grade I spondylolisthesis needing a one/two level surgical treatment with posterior approach and screw fixation
- those who need a surgical procedure of lumbar spine stabilization from level L1 to level L5.
- patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to the patient's surgery
- Healthy patients or patients with mild or severe systemic disease identified as patients with ASA score 1, 2 or 3.
- Patients with BMI ≤ 35 kg/m2
- non responsive or insufficient response to conservative treatment.
Exclusion Criteria:
- Patients presenting contraindications as defined by Medacta instruction for use
- Patients affected by lytic spondylolisthesis and degenerative spondylolisthesis with grade≥2 will be excluded
- Patients <18 years
- Patients who are pregnant or intend to become pregnant during the study
- Known substance or alcohol abuse
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
MySpine MC
spinal stabilization via cortical bone trajectory with the support of patient specific guide (MySpine MC technology)
|
patient specific guide for screw positioning
|
|
MySpine STD
spinal stabilization via standard pedicle screw positioning with the support of patient specific guide (MySpine std technology)
|
patient specific guide for screw positioning
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spine surgical patient outcome changing in the time respect the preoperative
Time Frame: baseline, 6 weeks, 3 months, 6 months, 12 months
|
Change in Core Outcome Measures Index (COMI) for the assessment of people affected by degenerative lumbar disease in daily practice
|
baseline, 6 weeks, 3 months, 6 months, 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spine Disability index
Time Frame: baseline, 6 weeks, 3 months, 6 months, 12 months
|
questionnaire for assessing functional status and quality-of-life impairment in patients with low back pain or spinal cord disease and injury in research and clinical settings. he index enquires about functional limitations in various activities of daily living with the index score ranging from 1 (best) to 100 (worst). Among others, pain intensity, personal hygiene, walking, sleeping, social life, sexual life (optional) and travel are assessed by the patient. Each section has six possible responses, which are scored from 0 to 5. |
baseline, 6 weeks, 3 months, 6 months, 12 months
|
|
Pain perception
Time Frame: baseline, 6 weeks, 3 months, 6 months, 12 months
|
A visual analog scale (from no pain "0" to severe pain "10") to evaluate low back pain
|
baseline, 6 weeks, 3 months, 6 months, 12 months
|
|
Bone fusion
Time Frame: baseline, 12 months
|
A postoperative CT scan will be performed to asses bone fusion at index level defining the presence of bridging bone.
|
baseline, 12 months
|
|
Incidence of adverse event Device-related
Time Frame: baseline, 6 weeks, 3 months, 6 months, 12 months
|
Colleciton of all adverse event for all study duration
|
baseline, 6 weeks, 3 months, 6 months, 12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: François Porchet, Dr, Schulthess Klinik
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P05.007.06
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
Centinel SpineAvaniaEnrolling by invitationDegenerative Disc Disease | Symptomatic Cervical Disc Disease | Cervical Spine Degenerative Disc Disease | Cervical Spine Degenerative DiseaseGermany
-
Synergy Spine SolutionsMCRAActive, not recruitingCervical Degenerative Disc DiseaseUnited States
-
Orthofix Inc.TerminatedCervical Degenerative Disc DiseaseUnited States
-
Assiut UniversityNot yet recruiting
-
Spine BioPharma, IncMCRAActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
AxioMed Spine CorporationUnknownDegenerative Disc Disease (DDD)United States, Germany
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom
-
Yuhan CorporationCompletedDisc Degenerative DiseaseKorea, Republic of
Clinical Trials on MySpine
-
Medacta International SACompleted
-
Medacta International SACompletedSpinal Deformity